ArticleCell chemical biology2024

Differential network analysis of ROS1 inhibitors reveals lorlatinib polypharmacology through co-targeting PYK2.

Yi Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.